Researchers explore the anxiolytic effects of cannabis for COVID-19-induced anxiety
The data of 2,306 participants were assessed to track their consumption of…
NVX-CoV2373 enters Phase 3 trial for combatting SARS-CoV-2
Novavax is now enrolling adult volunteers in the United States and in…
Infants do not seem to be much affected by SARS-CoV-2
The research was released in JAMA Network Open.
Patients who are infected with COVID-19 are at a lower risk of reinfection
It is speculated that such antibodies could last for as much as…
Women experiencing more mental health problems as a result of COVID-19 isolation
Researchers unmasked a slew of mental health problems women, in particular, have…
Most Americans say they changed their holiday plans due to COVID-19 pandemic
The survey took place in mid-November 2020.
BioNTech-Pfizer COVID-19 vaccine labeled as safe for wide-scale distribution by the EU
The European Medicines Agency greenlighted its approval by reassuring the vaccine meets…
13 percent of US adults report severe mental distress during COVID-19 pandemic
The survey touched on numerous factors including employment, finances, education, and health…
Moderna’s COVID-19 vaccine touted as strongly effective by FDA advisers
FDA advisers recommend Moderna's mRNA-1273 for immediate use to combat COVID-19.
Study shows shrugging CDC guidelines results in anxiety and anger in the workplace
The study was authored by Renata Guzzo, Xingyu Wang, Juan Madera, and…
Many populations might not be able to get a COVID-19 vaccine until 2022, research claims
For the study, researchers evaluated the pre-order data of vaccines used against…
COVID-19 infection may result in neurological disorders by invasion of central nervous system
The study was released in Cells.